Trademark: 88314433
Word
PAPA & BARKLEY RELEAF
Status
Pending
Status Code
688
Status Date
Tuesday, February 20, 2024
Serial Number
88314433
Mark Type
3000
Filing Date
Monday, February 25, 2019
Published for Opposition
Tuesday, December 26, 2023

Trademark Owner History
Egg Rock Holdings, LLC - Owner At Publication

Classifications
5 Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabichromene solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabielsoin solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabinol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabinodiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabidiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabicitran solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabimovone solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabichromene solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabielsoin solely derived from Cannabis sativa L. with a delta9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabinol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabinodiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabidiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabicitran solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabimovone solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabichromene solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabielsoin solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabinol solely derived from Cannabis sativa L. with a delta9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabinodiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabidiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabicitran solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabimovone solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient, all of the foregoing containing no cannabis and no cannabinoids
3 Essential oils for cosmetic purposes, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Essential oils for cosmetic purposes, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body oils, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body oils, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body oils in drop form, capsule form, and liquid form, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body oils in drop form, capsule form, and liquid form, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body ointments, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body ointments, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body ointments in drop form and liquid form, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body ointments in drop form and liquid form, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Non-medicated body soaks, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Nonmedicated body soaks, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Electronic cigarette liquid (e-liquid) comprised of essential oils, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Electronic cigarette liquid (e-liquid) comprised of essential oils, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
The mark consists of the stylized wording "PAPA & BARKLEY RELEAF" in blue. In between the words "PAPA" and "BARKLEY" is the ampersand sitting inside a blue outline of a circle with a narrow blue leaf running through the ampersand. The wording "RELEAF" sits below the wording "PAPA". The white in the drawing is for background areas only and is not a feature of the mark.
PAPA AND BARKLEY RELIEF
The color(s) blue is/are claimed as a feature of the mark.

Trademark Events
Feb 20, 2024
Noa E-Mailed - Sou Required From Applicant
Dec 26, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 26, 2023
Published For Opposition
Dec 6, 2023
Notification Of Notice Of Publication E-Mailed
Nov 21, 2023
Exparte Appeal Terminated
Nov 21, 2023
Approved For Pub - Principal Register
May 3, 2023
Jurisdiction Restored To Examining Attorney
Feb 25, 2023
Notification Of Action Denying Req For Recon E-Mailed
Feb 25, 2023
Action Denying Req For Recon E-Mailed
Feb 25, 2023
Action Continuing Final - Completed
Oct 20, 2022
Teas/Email Correspondence Entered
Oct 20, 2022
Correspondence Received In Law Office
Oct 20, 2022
Assigned To Lie
Oct 14, 2022
Teas Request For Reconsideration Received
Jul 5, 2022
Jurisdiction Restored To Examining Attorney
Apr 14, 2022
Notification Of Subsequent Final Emailed
Apr 14, 2022
Subsequent Final Emailed
Apr 14, 2022
Subsequent Final Refusal Written
Oct 23, 2021
Teas/Email Correspondence Entered
Oct 22, 2021
Correspondence Received In Law Office
Oct 22, 2021
Teas Response To Office Action Received
Apr 26, 2021
Notification Of Non-Final Action E-Mailed
Apr 26, 2021
Non-Final Action E-Mailed
Apr 26, 2021
Non-Final Action Written
Jan 4, 2021
Divisional Processing Complete
Jan 4, 2021
Divisional Processing Complete
Dec 14, 2020
Divisional Request Received
Dec 15, 2020
Teas/Email Correspondence Entered
Dec 15, 2020
Correspondence Received In Law Office
Dec 15, 2020
Teas/Email Correspondence Entered
Dec 14, 2020
Correspondence Received In Law Office
Dec 14, 2020
Teas Voluntary Amendment Received
Dec 14, 2020
Teas Voluntary Amendment Received
Dec 14, 2020
Jurisdiction Restored To Examining Attorney
Dec 14, 2020
Ex Parte Appeal-Instituted
Dec 14, 2020
Exparte Appeal Received At Ttab
Dec 14, 2020
Teas Request To Divide Received
Dec 13, 2020
Teas Request For Reconsideration Received
Jun 13, 2020
Notification Of Final Refusal Emailed
Jun 13, 2020
Final Refusal E-Mailed
Jun 13, 2020
Final Refusal Written
May 12, 2020
Divisional Processing Complete
Apr 29, 2020
Divisional Request Received
May 11, 2020
Case Assigned To Intent To Use Paralegal
May 11, 2020
Teas/Email Correspondence Entered
Apr 29, 2020
Correspondence Received In Law Office
May 4, 2020
Assigned To Lie
Apr 29, 2020
Teas Response To Office Action Received
Apr 29, 2020
Teas Request To Divide Received
Oct 29, 2019
Notification Of Non-Final Action E-Mailed
Oct 29, 2019
Non-Final Action E-Mailed
Oct 29, 2019
Non-Final Action Written
Oct 28, 2019
Assigned To Examiner
May 6, 2019
Assigned To Examiner
May 6, 2019
Assigned To Examiner
Mar 21, 2019
Notice Of Design Search Code E-Mailed
Mar 15, 2019
New Application Office Supplied Data Entered
Feb 28, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24